Everyone is talking about or using weight loss products. So, the government pounces. A batch of 17 drugs are on a list of ...

Some workers are willing to trade vacation days or go back to the office in exchange for weight-loss drug coverage by their ...

Some Medicare plans may help cover the cost of mail-order drugs ... It’s more likely that your doctor would prescribe Wegovy, which contains semaglutide, the same active ingredient that ...

The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022.

Blue Cross Blue Shield of Michigan reported a hefty $1.03 billion loss in 2024 as rising costs in the sector batter the health insurer's bottom line in “unsustainable” market conditions.

Health insurance companies are lobbying against proposals that would expand prescription access to weight-loss medications.

The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the ...

Semaglutide — the key ingredient in Ozempic and Wegovy — had been in shortage since 2022. Now that supply has stabilized, state-licensed compounding pharmacies and physicians must stop selling ...

Many employers and insurers are scaling back coverage of Wegovy and Zepbound and a ... show Americans favor having Medicaid and Medicare cover the costs. Leaders at Zepbound maker Eli Lilly ...

The government is not allowed to cover the drugs for weight loss, which kept the cost to Medicare down. However, with the FDA approvals of Wegovy for cardiovascular benefits, plus Ozempic for ...